Guide for paediatric radiotherapy procedures

Cancer/Radiothérapie - Tập 26 - Trang 356-367 - 2022
A. Laprie1, V. Bernier2, L. Padovani3,4, V. Martin5, C. Chargari6,7, S. Supiot8,9, L. Claude10
1Département d’oncologie radiothérapie, Institut universitaire du cancer de Toulouse-Oncopole (IUCT-oncopole), université Paul-Sabatier Toulouse III, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France
2Département d’oncologie radiothérapie, Institut de cancérologie de Lorraine centre Alexis-Vautrin, 6, avenue de Bourgogne, CS 30519, 54519 Vandœuvre-lès-Nancy cedex, France
3Département de cancérologie radiothérapie, CHU, 13000 Marseille, France
4Université Aix-Marseille, 13000 Marseille, France
5Département de cancérologie radiothérapie, institut Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France
6Département d’oncologie radiothérapie, institut Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France
7Service de santé des armées, 75000 Paris, France
8Département de radiothérapie, Institut de cancérologie de l’Ouest (ICO) centre René-Gauducheau, 44800 Saint-Herblain, France
9Université de Nantes, 44000 Nantes, France
10Département d’oncologie radiothérapie, centre Léon-Bérard, 28, rue Laennec, 69373 Lyon cedex 08, France

Tài liệu tham khảo

Robison, 2014, Survivors of childhood and adolescent cancer: Life-long risks and responsibilities, Nat Rev Cancer, 14, 61, 10.1038/nrc3634 Claude, 2019, Update in pediatric nasopharyngeal undifferentiated carcinoma, Br J Radiol, 92, 20190107, 10.1259/bjr.20190107 Keller, 2018, Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: a report from the Children's Oncology Group, Cancer, 124, 3210, 10.1002/cncr.31519 Irtan, 2016, Wilms tumor: “State-of-the-art” update, 2016, Semin Pediatr Surg, 25, 250, 10.1053/j.sempedsurg.2016.09.003 Noël, 2022, Organs at risk radiation dose constraints, Cancer Radiother, 26 Kalapurakal, 2019, Cardiac-sparing whole lung IMRT in patients with pediatric tumors and lung metastasis: final report of a prospective multicenter clinical trial, Int J Radiat Oncol Biol Phys, 103, 28, 10.1016/j.ijrobp.2018.08.034 Claude, 2011, New radiation techniques in paediatric cancers, Bull Cancer, 98, 571, 10.1684/bdc.2011.1350 Habrand, 2009, [Proton beam therapy in pediatric radiotherapy], Cancer Radiother, 13, 550, 10.1016/j.canrad.2009.07.001 Hess, 2018, An update from the Pediatric Proton Consortium Registry, Front Oncol, 8, 165, 10.3389/fonc.2018.00165 Régnier, 2019, Reirradiation of locally recurrent pediatric intracranial ependymoma: Experience of the French society of children's cancer, Radiother Oncol, 132, 1, 10.1016/j.radonc.2018.11.009 Bernier-Chastagner, 2012, [Stereotactic radiotherapy in pediatric indications], Cancer Radiother, 16, S111, 10.1016/j.canrad.2011.09.003 Alcorn, 2018, Practice patterns of stereotactic radiotherapy in pediatrics: results from an international pediatric research consortium, J Pediatr Hematol Oncol, 40, 522, 10.1097/MPH.0000000000001290 Amsbaugh, 2016, Stereotactic ablative radiotherapy for a lung metastasis in a child with Ewing's sarcoma, J Pediatr Hematol Oncol, 38, e199, 10.1097/MPH.0000000000000617 Brown, 2014, Stereotactic body radiotherapy for metastatic and recurrent Ewing sarcoma and osteosarcoma, Sarcoma, 2014, 418270, 10.1155/2014/418270 Deck, 2019, Efficacy and tolerability of stereotactic body radiotherapy for lung metastases in three patients with pediatric malignancies, Onco Targets Ther, 12, 3723, 10.2147/OTT.S194812 Combs, 2005, Recurrent low-grade gliomas: The role of fractionated stereotactic reirradiation, J Neurooncol, 71, 319, 10.1007/s11060-004-2029-z Claude Defez, 2019, OC-0171 Hypofractionated SBRT in childhood cancer: preliminary results of a national prospective study, Radiother Oncol, 133Suppl1, S83, 10.1016/S0167-8140(19)30591-2 Magné, 2010, Technical aspects and perspectives of the vaginal mold applicator for brachytherapy of gynecologic malignancies, Brachytherapy, 9, 274, 10.1016/j.brachy.2009.08.014 Lautz, 2020, Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children's Oncology Group, the European Soft-Tissue Sarcoma Group, and the Cooperative Weichteilsarkom Studiengruppe, Pediatr Blood Cancer, 6, e28601 Fuchs, 2016, Conservative surgery with combined high dose rate brachytherapy for patients suffering from genitourinary and perianal rhabdomyosarcoma, Radiother Oncol, 121, 262, 10.1016/j.radonc.2016.10.010 Chargari, 2017, Pulsed-dose rate brachytherapy for pediatric bladder prostate rhabdomyosarcoma: Compliance and early clinical results, Radiother Oncol, 124, 285, 10.1016/j.radonc.2017.07.010 INCa : cancers de l’enfant et de l’adolescent [Internet]. https://www.e-cancer.fr/Professionnels-de-sante/L-organisation-de-l-offre-de-soins/Cancerologie-pediatrique/Les-specificites-des-cancers-des-enfants-et-des-adolescents. Vigneron, 2013, [General anesthesia in pediatric radiotherapy], Cancer Radiother, 17, 534, 10.1016/j.canrad.2013.06.036 Claude, 2016, Radiothérapie des enfants de moins de cinq ans : peut-on limiter les anesthésies itératives par les rituels et l’hypnose ?, Bull Cancer, 103, 921, 10.1016/j.bulcan.2016.09.012 Chi, 2009, Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor, J Clin Oncol, 27, 385, 10.1200/JCO.2008.18.7724 Merchant, 2002, Preliminary results from a Phase II trail of conforml radiation therapy for pediatric patients with localised low-grade astrocytoma and ependymoma, Int J Radiat Oncol Biol Phys, 52, 325, 10.1016/S0360-3016(01)01807-7 Padovani, 2012, Neurocognitive function after radiotherapy for paediatric brain tumours, Nat Rev Cancer, 8, 578 Moxon-Emre, 2014, Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma, J Clin Oncol, 32, 1760, 10.1200/JCO.2013.52.3290 Carrie, 2009, Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98, J Clin Oncol, 27, 1879, 10.1200/JCO.2008.18.6437 Vieira, 2014, Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): A retrospective review, Radiat Oncol, 9, 158, 10.1186/1748-717X-9-158 Carrie, 2020, Exclusive hyperfractionated radiation therapy and reduced boost volume for standard-risk medulloblastoma: pooled analysis of the 2 French multicentric studies MSFOP98 and MSFOP 2007 and correlation with molecular subgroups, Int J Radiat Oncol Biol Phys, 108, 1204, 10.1016/j.ijrobp.2020.07.2324 Laprie, 2004, High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification, Cancer, 101, 1081, 10.1002/cncr.20453 Liu, 2020, Prospective evaluation of radiation dose escalation in patients with high-Risk neuroblastoma and gross residual disease after Surgery: A report from the children's oncology group ANBL0532 study, J Clin Oncol, 38, 2741, 10.1200/JCO.19.03316 Kalapurakal, 2003, Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms’ tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms’ Tumor Study Group, Int J Radiat Oncol, 57, 495, 10.1016/S0360-3016(03)00598-4 Padovani, 2009, Interclinician variability in making dosimetric decisions in pediatric treatment: A balance between efficacy and late effects, Radiother Oncol, 93, 372, 10.1016/j.radonc.2009.05.024 Hill-Kayser, 2013, Proton versus photon radiation therapy for patients with high-risk neuroblastoma: The need for a customized approach, Pediatr Blood Cancer, 60, 1606, 10.1002/pbc.24606 Jouglar, 2016, Can we spare the pancreas and other abdominal organs at risk?. A comparison of conformal radiotherapy, helical tomotherapy and proton beam therapy in pediatric irradiation, PLoS One, 11, e0164643, 10.1371/journal.pone.0164643 Hua, 2020, Practice patterns and recommendations for pediatric image-guided radiotherapy: A Children's Oncology Group report, Pediatr Blood Cancer, 67, e28629, 10.1002/pbc.28629 Hoeben, 2019, Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group, Lancet Oncol, 20, e155, 10.1016/S1470-2045(19)30034-8 Weil, 2018, Late infection-related mortality in asplenic survivors of childhood cancer: A report from the childhood cancer survivor study, J Clin Oncol, 36, 1571, 10.1200/JCO.2017.76.1643 Aleman, 2003, Long-term cause-specific mortality of patients treated for Hodgkin's disease, J Clin Oncol, 21, 3431, 10.1200/JCO.2003.07.131 Metwally, 2011, Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition, Int J Radiat Oncol Biol Phys, 80, 793, 10.1016/j.ijrobp.2010.02.024 Starke, 2018, Comparison of butterfly volumetric modulated arc therapy to full arc with or without deep inspiration breath hold for the treatment of mediastinal lymphoma, Radiother Oncol, 129, 449, 10.1016/j.radonc.2018.08.017 Knäusl, 2013, Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?, Strahlenther Onkol, 189, 54, 10.1007/s00066-012-0235-8 Rutenberg, 2014, Proton therapy for Hodgkin lymphoma, Curr Hematol Malig Rep, 9, 203, 10.1007/s11899-014-0212-7 Buszek, 2019, Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma, Pediatr Blood Cancer, 66, e27952, 10.1002/pbc.27952 Ludmir, 2019, Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma, Radiother Oncol, 134, 143, 10.1016/j.radonc.2019.02.002 Chargari, 2017, Brachytherapy combined with surgery for conservative treatment of children with bladder neck and/or prostate rhabdomyosarcoma, Int J Radiat Oncol Biol Phys, 98, 352, 10.1016/j.ijrobp.2017.02.026 Orbach, 2008, Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects, Pediatr Blood Cancer, 50, 849, 10.1002/pbc.21372